ACS Biotech has developed a cartilage repair product based on the chondrocyte transplantation technique.
ACS Biotech has developed a new product based on the optimization of the transplantation chondrocytes technique with chitosan as a support for cells. Our innovative 3D matrix composed with chitosan hydrogel and associated with chondrocyte yields to a cartilage gel like hyaline (patented).
ACS Biotech aims at proposing a solution:
– Reliable & safe
– Durable with one shot injection
– With a perfect control of cells and cartilage matrix before use
– Reparative to cure patients with cartilage defects all around the world